CG:600557 Jiangsu Kanion Pharmaceutical Co.,Ltd

Jiangsu Kanion Pharmaceutical Co., Ltd. is a China-based company principally engaged in the research, development, manufacture and distribution of pharmaceuticals. The Company provides capsules, oral liquid, granules, electuary, tablets, pills and injections, including anti-hyperosteogeny capsules, sanqi tablets, tianshu capsules, telmisartan capsules, liuwei dihuang soft capsule, antiviraloral liquid, jinzhen oral liquid and others. The Company distributes its products primarily in domestic market. Through its subsidiaries, the Company also involves in the sales of Chinese patent medicines.

10.95 CNY
As of 01/25/2022


Security Information
Category1:  Global Equity
Category2:  Common stocks
Category3:  Emerging markets
GICS sector:  Health Care
Industry:  Drug Manufacturers-Specialty &
Index country:  China
Country of incorporation:  China
IPO date:  09/19/2002
Stock exchange:    Shanghai Stock Exchange
Exchange country:   China
Market cap:   6,492,046,848 CNY
Current dividend yield:   0.67%
Sedol:      

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy